Article Details

NGM Bio Announces Topline Results from the CATALINA Phase 2 Trial of NGM621 in ...

Retrieved on: 2022-10-17 16:19:54

Tags for this article:

Click the tags to see associated articles and topics

NGM Bio Announces Topline Results from the CATALINA Phase 2 Trial of NGM621 in .... View article details on hiswai:

Excerpt

Details: Category: Antibodies: Published on Monday, 17 October 2022 18:10 ... NGM621 is a humanized immunoglobulin G1 (IgG1) monoclonal antibody ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up